Type a Aortic Dissection
13
2
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
Outcomes of Aortic Dissection Repair
Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)
European Registry of Type A Aortic Dissection
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
Impact of RIVP on GI Function in Patients Undergoing Surgical Repair for ATAAD
Prediction Models for Postoperative Reintubation in Patients With Acute Aortic Dissection
Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ )
Surgical Management of the Aortic Root and Long-term Outcomes For Acute Type A Aortic Dissection
BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients
iNO as Salvage Treatment of Hypoxemia After TAAD Surgery
Antegrade Cerebral Perfusion and Retrograde Inferior Vena Caval Perfusion for Total Aortic Arch Replacement
Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery